ArticleAnnals of hematology2021

Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphoma.

Zhiyuan Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.